Top Markets
#1 Pleasing Gold Pleasing Gold +1,501.98%
#2 Ontology Gas Ontology Gas +137.89%
#3 PulseChain PulseChain +57.64%
#4 ConstitutionDAO ConstitutionDAO +37.37%
#5 Osmosis Osmosis +32.13%
#6 BOOK OF MEME BOOK OF MEME +31.44%
#7 Ontology Ontology +29.58%
#8 Neiro Neiro +29.12%
#9 Collect on Fanable Collect on Fanable +28.57%
#10 Pump.fun Pump.fun +27.30%
Coin of the day
Pleasing Gold Pleasing Gold
설정
언어
한국어
통화
USD
테마
Icosavax, Inc. Icosavax, Inc.

Icosavax, Inc.

ICVX
주식 순위 #25853
Icosavax, Inc. operates as a biopharmaceutical firm dedicated to developing... Icosavax, Inc. operates as a biopharmaceutical firm dedicated to developing immunizations against infectious diseases. Leveraging its proprietary virus-like particle (VLP) platform technology, the company primarily focuses its efforts on severe respiratory illnesses. Its developmental portfolio includes several key vaccine candidates: IVX-121, an RSV-targeted vaccine currently undergoing Phase 1/1b clinical trials; IVX-A12, a bivalent candidate designed to target both respiratory syncytial virus (RSV) and human metapneumovirus (hMPV); IVX-241, a candidate specifically designed for hMPV; and IVX-411, a SARS-CoV-2 vaccine based on a receptor binding domain (RBD) sequence antigen, which is also in Phase 1/2 clinical trials. Established in 2017, Icosavax maintains its corporate headquarters in Seattle, Washington.
주가
$15.31
마지막 동기화: 2024-02-29
시가총액
$45.70M
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Icosavax, Inc. (ICVX)

카테고리

Healthcare
Icosavax, Inc. (ICVX)의 주가 이력
최고 종가: $15.31 (2024-02-01 기준)

최저 종가: $29.91 (2021-07-01 기준)
Icosavax, Inc.의 주가 이력 (2021 ~ 2026)
연간 주가 성과
연도 성과
2024 10.83%
2023 104.14%
2022 -70.48%
2021 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $539.14 36.71%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 56.86%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $120.74 -14.98%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $761.87 7.04%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $130.43 385.07%
US